Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome …

JD Cartledge, J Midgely, BG Gazzard - Journal of clinical pathology, 1997 - jcp.bmj.com
AIMS: To compare the serum concentrations of itraconazole and hydroxyitraconazole after
treatment with itraconazole cyclodextrin solution and itraconazole capsules in human …

Diffuse white matter signal abnormalities on magnetic resonance imaging are associated with human immunodeficiency virus type 1 viral escape in the central …

R Kugathasan, DA Collier, LJ Haddow… - Clinical Infectious …, 2017 - academic.oup.com
Background. Human immunodeficiency virus type 1 (HIV-1) can replicate independently in
extravascular compartments such as the central nervous system, resulting in either …

Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis

JD Cartledge, J Midgley, BG Gazzard - Aids, 1997 - journals.lww.com
Objectives: To determine the proportion of fluconazole-resistant Candida albicans isolates
that have clinically significant cross-resistance to itraconazole or ketoconazole, that is …

Non-albicansoralcandidosis in HIV-positive patients

JD Cartledge, J Midgley… - Journal of Antimicrobial …, 1999 - academic.oup.com
Specimens from HIV-positive patients with oral candidosis were taken for culture, species
identification and azole susceptibility testing, which was correlated with treatment outcome …

Dissemination of Strongyloides stercoralis as an immune restoration phenomenon in an HIV-1-infected man on antiretroviral therapy

M Brown, JD Cartledge… - International journal of …, 2006 - journals.sagepub.com
We present a case of Strongyloides stercoralis infection in an HIV-infected man, resulting in
Escherichia coli meningitis after initiation of antiretroviral therapy. Recent evidence from …

Itraconazole cyclodextrin solution: the role ofin vitrosusceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole …

JD Cartledge, J Midgley, BG Gazzard - Aids, 1997 - journals.lww.com
Objectives: This study assessed the ability of in vitro susceptibility testing of clinical Candida
isolates to predict in vivo response to itraconazole cyclodextrin solution. Methods: One …

Cross-sectional study of unexplained white matter lesions in HIV positive individuals undergoing brain magnetic resonance imaging

LJ Haddow, C Dudau, H Chandrashekar… - AIDS Patient Care …, 2014 - liebertpub.com
White matter (WM) abnormalities are frequently seen on brain MRI of HIV positive (HIV+)
patients. We aimed to determine the prevalence of unexplained WM abnormalities and their …

Management of pulmonary aspergillosis in AIDS: an emerging clinical problem.

JJ Keating, T Rogers, M Petrou, JD Cartledge… - Journal of clinical …, 1994 - jcp.bmj.com
AIMS--To review the clinical, radiographic, and therapeutic features of 11 cases of
respiratory Aspergillus infection in patients with AIDS. METHODS--All induced sputum and …

Imaging features of multicentric Castleman's disease in HIV infection

JC Hillier, P Shaw, RF Miller, JD Cartledge, M Nelson… - Clinical radiology, 2004 - Elsevier
AIM: To describe the computed tomography (CT) features of human immunodeficiency virus
(HIV)-associated Castleman's disease. MATERIALS AND METHODS: Nine HIV-positive …

Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.

JD Cartledge, J Midgley, M Petrou… - The Journal of …, 1997 - academic.oup.com
Azole-resistant HIV-related candidosis is increasingly recognized. We evaluated two new in-
vitro susceptibility tests (the NCCLS proposed MIC method and Odds' assessment of relative …